Featured Story

Beaumont, Royal Oak breaks ground on Proton Therapy Center to treat cancer

Construction has begun on a new Proton Therapy Center at Beaumont Hospital’s Cancer Institute in Royal Oak. Proton therapy is a newer, high-tech alternative to treating certain cancers. The benefits: a scanning beam of proton radiation with online image guidance offers greater precision to destroy cancerous cells, sparing healthy tissue with fewer side effects. This will be the first single-room proton treatment center of its kind in Michigan.

Read More

Detroit Riverfront hosts Beaumont Children’s Hospital Torch Relay

Metro Detroit is one of 19 cities across the country participating in the annual Torch Relay walk that raises funds for Children’s Miracle Network Hospital affiliates including Beaumont Children’s Hospital. Torch Relay is a three mile walk that takes place at the Rivard Plaza along the Detroit Riverfront on Sunday, October 5 at 9:30 a.m. Last

Beaumont Health System to stop furniture purchases with toxins

Beaumont Health System has joined Advocate Health Care, Hackensack University Medical Center and University Hospitals in a commitment to stop purchasing furniture treated with toxic flame retardant chemicals.

Beaumont Health CEO names executive team

Beaumont Health President and CEO Gene Michalski has named the top executive team for the new $3.8 billion health care organization that combined Beaumont Health System, Botsford Health Care and Oakwood Healthcare.

Beaumont Children’s Hospital doctor: ‘Autism-appearing condition is treatable’

Autism spectrum disorder can include a wide range of symptoms from avoiding eye contact to performing rituals, or sometimes even losing the ability to communicate. A child who exhibits such behaviors may not actually have autism. Meet Spencer Kaleniecki. He was diagnosed with autism at 2-1/2-years-old.

Beaumont research: Biomarkers predict fetal heart defects found in the first trimester

An international study led by Beaumont Health System chair of Obstetrics and Gynecology, Ray Bahado-Singh, M.D., has identified biomarkers for the prediction of fetal heart defects. Findings are published in the Sept. 5 issue of the American Journal of Obstetrics & Gynecology. Prior to Dr. Bahado-Singh’s research, these markers have never been tested or reported.